GTx, Inc announced the submission of a New Drug Application with the US Food and Drug Administration (FDA) for toremifene 80 mg, an oral selective estrogen receptor modulator (SERM), for the prevention of bone fractures in men with prostate cancer on androgen deprivation therapy (ADT).
According to Dr Mitchell Steiner, CEO of GTx, ADT has helped […]

continue reading from " GTx submits NDA for toremifene to treat bone fractures in men with prostate cancer "

Nearly 300,000 men are diagnosed with prostate cancer each year, and they need more than medical treatment. Man to Man is an American Cancer Society program designed to help men with prostate cancer by providing community-based education and support to patients and their family members.
Man to Man provides an opportunity for men dealing with prostate […]

continue reading from " Nutrition is an important part of therapy for prostate cancer treatment "

Prostate cancer cells rely on androgens, male hormones that include testosterone, to survive and grow.
This hormone deprivation therapy causes tumours to shrink, however, it’s never a cure. They tumours eventually regrow into a stronger form, becoming resistant to treatment.
The results suggest that hormone therapy might encourage prostate cancer cells to overproduce the AR-V7 receptors over […]

continue reading from " Why prostate cancer patients become resistant to hormone deprivation therapy "

The Ontario government recently announced it will cover the cost of the prostate-specific antigen tests when performed at laboratories.
Currently, publicly funded tests are only available in hospitals, but picking up the tab for those performed in laboratories will make it more convenient for rural patients to be tested.
The blood test measures the amount of prostate-specific […]

continue reading from " Another prostate cancer obstacle set aside "

A new scan could help tell the difference between aggressive prostate cancers and harmless slow-growing ones.
It’s hoped the technique, being developed at the Institute of Cancer Research in Sutton, Surrey, will save thousands of men from unnecessary biopsies.
It uses a form of magnetic resonance imaging (MRI) to identify which tumours are potential killers and which […]

continue reading from " The prostate scan may distinguish the killers from the slow prostate cancers "

The American Cancer Society recommends that men with a family history of prostate cancer get screened for the disease starting at age 45. However, some studies have found that these men are no more likely to seek screening than those without a family history.
These latest findings, published in the journal Cancer Epidemiology, Biomarkers and Prevention, […]

continue reading from " Men who live alone fall short on prostate screening "

The U.S. National Library of Medicine says more than half of men with an enlarged prostate don’t have any symptoms. But if symptoms are present, they may include:
Urination that starts slowly and continues in a weak stream.Urination that becomes difficult, if not nearly impossible.The need to urinate suddenly, urgently and frequently — at least twice […]

continue reading from " Warning Signs of Enlarged Prostate "

A study published today in the December issue of the European medical journal Anticancer Research demonstrates that an ingredient used in a common cough suppressant may be useful in treating advanced prostate cancer.
Researchers found that noscapine, which has been used in cough medication for nearly 50 years, reduced tumor growth in mice by 60 percent […]

continue reading from " A cough medicine ingredient could effectively treat prostate cancer; study found "

If you are scheduled for a PSA screening test you must ask your doctor if you should avoid taking any of your medications, over-the-counter painkillers or prescription painkillers or any other medications anytime before the test.
That’s one good way to help get a better PSA reading, as a new study reports that taking certain painkillers […]

continue reading from " Painkillers can cause problems in prostate cancer detection "

Alfuzosin, a drug commonly prescribed for men with chronic prostatitis, a painful disorder of the prostate and surrounding pelvic area, failed to significantly reduce symptoms in recently diagnosed men who had not been previously treated with this drug, according to a clinical trial sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases, […]

continue reading from " Common treatment for chronic prostatitis fails to reduce symptoms "